Richard Peters
2017 - Merrimack Pharmaceuticals
In 2017, Richard Peters earned a total compensation of $3.8M as President and Chief Executive Officer at Merrimack Pharmaceuticals.
Compensation breakdown
| Bonus | $900,000 |
|---|---|
| Non-Equity Incentive Plan | $533,160 |
| Option Awards | $1,710,400 |
| Salary | $619,231 |
| Other | $15,433 |
| Total | $3,778,224 |
Peters received $1.7M in option awards, accounting for 45% of the total pay in 2017.
Peters also received $900K in bonus, $533.2K in non-equity incentive plan, $619.2K in salary and $15.4K in other compensation.
Rankings
In 2017, Richard Peters' compensation ranked 2,749th out of 14,666 executives tracked by ExecPay. In other words, Peters earned more than 81.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,749 out of 14,666 | 81st |
Division Manufacturing | 951 out of 5,768 | 84th |
Major group Chemicals And Allied Products | 253 out of 2,074 | 88th |
Industry group Drugs | 192 out of 1,730 | 89th |
Industry Pharmaceutical Preparations | 153 out of 1,329 | 89th |
Source: SEC filing on April 27, 2018.
Peters' colleagues
We found six more compensation records of executives who worked with Richard Peters at Merrimack Pharmaceuticals in 2017.
2017
Jeffrey Munsie
Merrimack Pharmaceuticals
General Counsel
2017
Daryl Drummond
Merrimack Pharmaceuticals
Head of Research
2017
Sergio Santillana
Merrimack Pharmaceuticals
Chief Medical Officer
2017
Jean Franchi
Merrimack Pharmaceuticals
Chief Financial Officer
2017
Yasir Al-Wakeel
Merrimack Pharmaceuticals
Chief Financial Officer
2017
Gary Crocker
Merrimack Pharmaceuticals
Chief Executive Officer
News
KINETA CEO Richard MDPhD receives $4.5M in 2021
April 25, 2022
KINETA CEO Meenu Chhabra's 2020 pay jumps 65% to $3.3M
April 22, 2021
Merrimack Pharmaceuticals CEO Richard Peters' 2019 pay falls 51% to $1.6M
April 22, 2020
Merrimack Pharmaceuticals CEO Richard Peters' 2018 pay slips 13% to $3.3M
September 26, 2019